Picture of Eledon Pharmaceuticals logo

ELDN — Eledon Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Brief: Eledon Pharmaceuticals Reports Q1 Loss Per Share $0.57

May 13 (Reuters) - Eledon Pharmaceuticals Inc  ELDN.O :
    * ELEDON PHARMACEUTICALS REPORTS FIRST QUARTER 2021
OPERATING AND
FINANCIAL RESULTS
    * Q1 LOSS PER SHARE $0.57
    * Q1 EARNINGS PER SHARE ESTIMATE $-0.32 -- REFINITIV IBES
DATA
    * COMPANY HAD APPROXIMATELY $108.6 MILLION IN CASH AND CASH
EQUIVALENTS AS OF MARCH 31, 2021
    * BELIEVES THAT IT HAS SUFFICIENT FINANCIAL RESOURCES TO
FUND
OPERATIONS AS CURRENTLY PLANNED WELL INTO 2023.

Source text for Eikon:  ID:nGNX4Q7LdJ 
Further company coverage:  ELDN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Eledon Pharmaceuticals

See all news